Home > Boards > US Listed > Biotechs > Nabriva Therapeutics AG (NBRV)

Margin calls everywhere...time to be a vulture

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
noretreat Member Profile
 
Followed By 121
Posts 11,801
Boards Moderated 0
Alias Born 01/06/10
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/25/2020 4:16:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2020 8:00:53 AM
Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection GlobeNewswire Inc. - 6/19/2020 8:52:20 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/12/2020 4:25:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:08:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:08:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:07:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:07:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:06:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 6:06:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2020 7:03:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/1/2020 7:02:15 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/1/2020 6:56:02 AM
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 5/29/2020 7:31:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 9:02:19 AM
Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pne... GlobeNewswire Inc. - 5/29/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2020 4:06:17 PM
Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/27/2020 4:01:10 PM
National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Culture... GlobeNewswire Inc. - 5/18/2020 8:00:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2020 4:23:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 4:16:58 PM
Nabriva Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Updates GlobeNewswire Inc. - 5/11/2020 4:01:10 PM
Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference GlobeNewswire Inc. - 5/11/2020 7:00:10 AM
Nabriva Therapeutics to Report First Quarter 2020 Financial Results on May 11, 2020 GlobeNewswire Inc. - 5/8/2020 7:00:10 AM
XENLETA® (Lefamulin) Treatment Results in a Rapid Time-to-Clinical Response in Hospitalized Patients with Community-Acquired... GlobeNewswire Inc. - 5/5/2020 7:00:10 AM
noretreat   Sunday, 03/15/20 04:48:10 PM
Re: DorseyE post# 205
Post # of 345 
Margin calls everywhere...time to be a vulture

No Retreat ... No Surrender
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist